UK markets open in 3 hours 41 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.26+0.22 (+1.78%)
At close: 4:00PM EST

12.26 0.00 (0.00%)
After hours: 4:18PM EST

Full screen
Loading interactive chart…
  • Aerie (AERI) Gets Positive CHMP Opinion for Roclanda in EU
    Zacks

    Aerie (AERI) Gets Positive CHMP Opinion for Roclanda in EU

    Aerie (AERI) receives positive CHMP opinion for Roclanda for reduction of elevated intraocular pressure in adult patients.

  • Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union
    Business Wire

    Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union

    Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of the marketing authorisation application (MAA) for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. The recommended indication is the reduction of elevated intraocular pressure in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

  • Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
    Business Wire

    Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference

    Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside discussion at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 8:00 a.m. Eastern Time. Dr. Anido will provide an Aerie overview and a business update.